Low Dose Naltrexone for Glioma Patients
Condition(s):Malignant GliomaLast Updated:July 17, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Malignant GliomaLast Updated:July 17, 2015Completed
Condition(s):FibromyalgiaLast Updated:February 23, 2024Completed
Condition(s):Cannabis DependenceLast Updated:April 24, 2019Completed
Condition(s):Opiate Dependence; Human Immunodeficiency VirusLast Updated:November 6, 2020Completed
Condition(s):Fatigue Syndrome, ChronicLast Updated:September 2, 2022Withdrawn
Condition(s):Opioid-use DisorderLast Updated:September 14, 2020Completed
Condition(s):Eating Disorders; Binge Eating; Purging (Eating Disorders)Last Updated:October 12, 2023Completed
Condition(s):Crohn’s DiseaseLast Updated:September 6, 2018Completed
Condition(s):Alcohol Use DisorderLast Updated:December 8, 2023Completed
Condition(s):Osteoarthritis; Arthritis, Rheumatoid; Arthritis, PsoriaticLast Updated:March 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.